Drug resistance in epilepsy: expression of drug resistance proteins in common causes of refractory epilepsy - PubMed (original) (raw)
. 2002 Jan;125(Pt 1):22-31.
doi: 10.1093/brain/awf002.
Affiliations
- PMID: 11834590
- DOI: 10.1093/brain/awf002
Drug resistance in epilepsy: expression of drug resistance proteins in common causes of refractory epilepsy
S M Sisodiya et al. Brain. 2002 Jan.
Abstract
Epilepsy is resistant to drug treatment in about one-third of cases, but the mechanisms underlying this drug resistance are not understood. In cancer, drug resistance has been studied extensively. Amongst the various resistance mechanisms, overexpression of drug resistance proteins, such as multi-drug resistance gene-1 P-glycoprotein (MDR1) and multidrug resistance-associated protein 1 (MRP1), has been shown to correlate with cellular resistance to anticancer drugs. Previous studies in human epilepsy have shown that MDR1 and MRP1 may also be overexpressed in brain tissue from patients with refractory epilepsy; expression has been shown in glia and neurones, which do not normally express these proteins. We examined expression of MDR1 and MRP1 in refractory epilepsy from three common causes, dysembryoplastic neuroepithelial tumours (DNTs; eight cases), focal cortical dysplasia (FCD; 14 cases) and hippocampal sclerosis (HS; eight cases). Expression was studied immunohistochemically in lesional tissue from therapeutic resections and compared with expression in histologically normal adjacent tissue. With the most sensitive antibodies, in all eight DNT cases, reactive astrocytes within tumour nodules expressed MDR1 and MRP1. In five of eight HS cases, reactive astrocytes within the gliotic hippocampus expressed MDR1 and MRP1. Of 14 cases of FCD, MDR1 and MRP1 expression was noted in reactive astrocytes in all cases. In five FCD cases, MRP1 expression was also noted in dysplastic neurones. In FCD and DNTs, accentuation of reactivity was noted around lesional vessels. Immunoreactivity was always more frequent and intense in lesional reactive astrocytes than in glial fibrillary acidic protein-positive reactive astrocytes in adjacent histologically normal tissue. MDR1 is able to transport some antiepileptic drugs (AEDs), and MRP1 may also do so. The overexpression of these drug resistance proteins in tissue from patients with refractory epilepsy suggests one possible mechanism for drug resistance in patients with these pathologies. We propose that overexpressed resistance proteins lower the interstitial concentration of AEDs in the vicinity of the epileptogenic pathology and thereby render the epilepsy caused by these pathologies resistant to treatment with AEDs.
Similar articles
- Expression and cellular distribution of multidrug transporter proteins in two major causes of medically intractable epilepsy: focal cortical dysplasia and glioneuronal tumors.
Aronica E, Gorter JA, Jansen GH, van Veelen CW, van Rijen PC, Leenstra S, Ramkema M, Scheffer GL, Scheper RJ, Troost D. Aronica E, et al. Neuroscience. 2003;118(2):417-29. doi: 10.1016/s0306-4522(02)00992-2. Neuroscience. 2003. PMID: 12699778 - Expression and cellular distribution of multidrug resistance-related proteins in patients with focal cortical dysplasia.
Ak H, Ay B, Tanriverdi T, Sanus GZ, Is M, Sar M, Oz B, Ozkara C, Ozyurt E, Uzan M. Ak H, et al. Seizure. 2007 Sep;16(6):493-503. doi: 10.1016/j.seizure.2007.03.011. Epub 2007 May 7. Seizure. 2007. PMID: 17482840 - Drug resistance in epilepsy: human epilepsy.
Sisodiya SM, Lint WR, Harding BN, Squier MV, Thom M. Sisodiya SM, et al. Novartis Found Symp. 2002;243:167-74; discussion 174-9, 180-5. doi: 10.1002/0470846356.ch12. Novartis Found Symp. 2002. PMID: 11990775 - Vascular and parenchymal mechanisms in multiple drug resistance: a lesson from human epilepsy.
Marroni M, Marchi N, Cucullo L, Abbott NJ, Signorelli K, Janigro D. Marroni M, et al. Curr Drug Targets. 2003 May;4(4):297-304. doi: 10.2174/1389450033491109. Curr Drug Targets. 2003. PMID: 12699350 Review. - ABC transporters during epilepsy and mechanisms underlying multidrug resistance in refractory epilepsy.
Lazarowski A, Czornyj L, Lubienieki F, Girardi E, Vazquez S, D'Giano C. Lazarowski A, et al. Epilepsia. 2007;48 Suppl 5:140-9. doi: 10.1111/j.1528-1167.2007.01302.x. Epilepsia. 2007. PMID: 17910594 Review.
Cited by
- Blood-brain barrier transport of morphine in patients with severe brain trauma.
Ederoth P, Tunblad K, Bouw R, Lundberg CJ, Ungerstedt U, Nordström CH, Hammarlund-Udenaes M. Ederoth P, et al. Br J Clin Pharmacol. 2004 Apr;57(4):427-35. doi: 10.1046/j.1365-2125.2003.02032.x. Br J Clin Pharmacol. 2004. PMID: 15025740 Free PMC article. - Development of purine-derived 18F-labeled pro-drug tracers for imaging of MRP1 activity with PET.
Galante E, Okamura T, Sander K, Kikuchi T, Okada M, Zhang MR, Robson M, Badar A, Lythgoe M, Koepp M, Årstad E. Galante E, et al. J Med Chem. 2014 Feb 13;57(3):1023-32. doi: 10.1021/jm401764a. Epub 2014 Feb 4. J Med Chem. 2014. PMID: 24456310 Free PMC article. - Early Chronic Carbamazepine-in-Food Administration to MAM/Pilocarpine Rats Does Not Affect Convulsive Motor Seizures.
Nobili P, Cattalini A, de Grazia U, Cagnoli C, de Curtis M, Battaglia GS, Colciaghi F. Nobili P, et al. Front Pharmacol. 2020 Feb 28;11:181. doi: 10.3389/fphar.2020.00181. eCollection 2020. Front Pharmacol. 2020. PMID: 32180728 Free PMC article. - Inhibition of P-glycoprotein over-expression by shRNA-mdr1b in rat astrocytes.
Chen L, Cheng X, Tian L, Yang T, Hermann S, Zhou D. Chen L, et al. Neurochem Res. 2009 Mar;34(3):411-7. doi: 10.1007/s11064-008-9797-3. Epub 2008 Aug 2. Neurochem Res. 2009. PMID: 18677564
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials